NCT01616485View on ClinicalTrials.gov

Study to Evaluate Hemodynamic Response to to a Sublingual Dose of Glyceryl Trinitrate in Subjects Receiving TA-1790, Sildenafil Citrate, and Placebo

PHASE1CompletedINTERVENTIONAL

Enrollment

106

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions

Erectile Dysfunction

Interventions

DRUG

TA-1790

2 TA-1790 100 mg capsules

DRUG

Sildenafil citrate

2 sildenafil citrate 50 mg capsules

DRUG

Placebo

2 placebo capsules for TA-1790 100 mg capsules

DRUG

Nitrostat

glyceryl trinitrate tablet, USP 0.4 mg

Trial Locations (1)

Unknown

MDS Pharma Services, Phoenix

All Listed Sponsors

lead

VIVUS LLC

INDUSTRY

NCT01616485 - Study to Evaluate Hemodynamic Response to to a Sublingual Dose of Glyceryl Trinitrate in Subjects Receiving TA-1790, Sildenafil Citrate, and Placebo | Biotech Hunter | Biotech Hunter